Survival in nephroblastoma treated according to the trial and study SIOP-9/GPOH with respect to relapse and morbidity.

@article{Weirich2004SurvivalIN,
  title={Survival in nephroblastoma treated according to the trial and study SIOP-9/GPOH with respect to relapse and morbidity.},
  author={Angela Weirich and Roger Ludwig and Norbert Graf and Ulrich Abel and Ivo Leuschner and Gordan M. Vujanic and Otto Mehls and Joachim Boos and Joachim Beck and Brigitte Royer-Pokora and Paul Antoine Vo{\^u}te},
  journal={Annals of oncology : official journal of the European Society for Medical Oncology},
  year={2004},
  volume={15 5},
  pages={808-20}
}
BACKGROUND Recent Wilms' tumor (WT) trials and studies have tried to determine the minimal therapy needed for cure. The goal was survival without morbidity. PATIENTS AND METHODS From January 1989 to March 1994 the German Society of Pediatric Oncology and Hematology registered 440 patients (median age 2.9 years; 231 male, 209 female) with WTs (preoperative chemotherapy 362) for therapy according to the International Society of Pediatric Oncology Trial and Study 9. Therapy for relapse depended… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 27 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 42 references

Similar Papers

Loading similar papers…